Elevance Health Raises 2026 Guidance to $27 EPS After Beating Q2 Estimates

Elevance Health raised full-year adjusted EPS guidance to at least $27 following strong Q2 performance and strategic portfolio adjustments.

Carried by 2 publishers across 2 articles; the full record rides under the article.

Truth Foundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.